Industry Research Reports
Global Hypericin Market Insights, Forecast to 2030
Industry: Chemical & Material
Published Date: 2024-04-12
Pages: 77 Pages
Report ld: 2933148
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Hypericin Market Size(US$)
CAGR 2024-2030
6.7%
Market Size,2030
USD 68
Million
Market Snapshot
Market Size in 2024 (Value)
US$ 46 million
Market Forecast in 2030(Value)
US$ 68 million
CAGR
6.7%
Years Considered
2019-2030
Base Year
2024
Forecast Period
2024-2030
Source: Secondary research, interviews with experts, and QYResearch analysis
Hypericin is a natural compound found in the flowering plant Hypericum perforatum, commonly known as St. John's Wort. It is a red pigment with photodynamic and antiviral properties. Hypericin has been extensively studied for its potential therapeutic applications, including as an antidepressant, antiviral agent, and anticancer compound. It is known to interact with various biological mechanisms and has shown promising results in laboratory studies for its ability to inhibit viral replication and induce apoptosis in cancer cells. Hypericin's unique chemical structure makes it an intriguing compound for further exploration in pharmaceutical research and medical treatments.
The global Hypericin market is projected to grow from US$ 46 million in 2024 to US$ 68 million by 2030, at a Compound Annual Growth Rate (CAGR) of 6.7% during the forecast period.
The industry trend for Hypericin is driven by the increasing interest in natural and plant-derived compounds for therapeutic purposes. With a growing demand for alternative and complementary medicines, there is a notable focus on botanical ingredients with demonstrated health benefits. Hypericin, as a bioactive compound derived from St. John's Wort, fits this trend by offering potential antidepressant, antiviral, and anticancer properties. The pharmaceutical industry is exploring its applications in drug development, particularly in the treatment of viral infections and as a potential adjunct therapy for certain cancers. Additionally, the dietary supplement and nutraceutical industry is incorporating Hypericin into formulations targeting mental health and viral support, driving its market growth even further.
In terms of production side, this report researches the Hypericin production, growth rate, market share by manufacturers and by region (region level and country level), from 2019 to 2024, and forecast to 2030.
In terms of consumption side, this report focuses on the sales of Hypericin by region (region level and country level), by company, by Type and by Application. from 2019 to 2024 and forecast to 2030.
Report Covers:
This report presents an overview of global market for Hypericin, capacity, output, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2024, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Hypericin, also provides the consumption of main regions and countries. Highlights of the upcoming market potential for Hypericin, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Hypericin sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Hypericin market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Hypericin sales, projected growth trends, production technology, application and end-user industry.
MARKET SEGMENTATION
By Company
- Aktin Chemicals
- Youth Healthy
- Hubei Shinrezing Pharmaceutical
- Herbs-Tech
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- 98% Content
- Other Content
Segment by Application
- Nutraceutical
- Pharmaceutical
- Research
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Hypericin production/output of global and key producers (regions/countries). It provides a quantitative analysis of the production, and development potential of each producer in the next six years.
Chapter 3: Sales (consumption), revenue of Hypericin in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Hypericin manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 9: China by Type, and by Application, sales, and revenue for each segment.
Chapter 10: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 11: Middle East, Africa, Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 12: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Hypericin sales, revenue, price, gross margin, and recent development, etc.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 15: The main points and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 Hypericin Product Introduction
1.2 Market by Type
1.2.1 Global Hypericin Market Size by Type, 2019 VS 2023 VS 2030
1.2.2 98% Content
1.2.3 Other Content
1.3 Market by Application
1.3.1 Global Hypericin Market Size by Application, 2019 VS 2023 VS 2030
1.3.2 Nutraceutical
1.3.3 Pharmaceutical
1.3.4 Research
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Hypericin Production
2.1 Global Hypericin Production Capacity (2019-2030)
2.2 Global Hypericin Production by Region: 2019 VS 2023 VS 2030
2.3 Global Hypericin Production by Region
2.3.1 Global Hypericin Historic Production by Region (2019-2024)
2.3.2 Global Hypericin Forecasted Production by Region (2025-2030)
2.3.3 Global Hypericin Production Market Share by Region (2019-2030)
2.4 North America
2.5 Europe
2.6 China
2.7 Japan
3 Executive Summary
3.1 Global Hypericin Revenue Estimates and Forecasts 2019-2030
3.2 Global Hypericin Revenue by Region
3.2.1 Global Hypericin Revenue by Region: 2019 VS 2023 VS 2030
3.2.2 Global Hypericin Revenue by Region (2019-2024)
3.2.3 Global Hypericin Revenue by Region (2025-2030)
3.2.4 Global Hypericin Revenue Market Share by Region (2019-2030)
3.3 Global Hypericin Sales Estimates and Forecasts 2019-2030
3.4 Global Hypericin Sales by Region
3.4.1 Global Hypericin Sales by Region: 2019 VS 2023 VS 2030
3.4.2 Global Hypericin Sales by Region (2019-2024)
3.4.3 Global Hypericin Sales by Region (2025-2030)
3.4.4 Global Hypericin Sales Market Share by Region (2019-2030)
3.5 US & Canada
3.6 Europe
3.7 China
3.8 Asia (excluding China)
3.9 Middle East, Africa and Latin America
4 Competition by Manufactures
4.1 Global Hypericin Sales by Manufacturers
4.1.1 Global Hypericin Sales by Manufacturers (2019-2024)
4.1.2 Global Hypericin Sales Market Share by Manufacturers (2019-2024)
4.1.3 Global Top 10 and Top 5 Largest Manufacturers of Hypericin in 2023
4.2 Global Hypericin Revenue by Manufacturers
4.2.1 Global Hypericin Revenue by Manufacturers (2019-2024)
4.2.2 Global Hypericin Revenue Market Share by Manufacturers (2019-2024)
4.2.3 Global Top 10 and Top 5 Companies by Hypericin Revenue in 2023
4.3 Global Hypericin Sales Price by Manufacturers
4.4 Global Key Players of Hypericin, Industry Ranking, 2022 VS 2023 VS 2024
4.5 Analysis of Competitive Landscape
4.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
4.5.2 Global Hypericin Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.6 Global Key Manufacturers of Hypericin, Manufacturing Base Distribution and Headquarters
4.7 Global Key Manufacturers of Hypericin, Product Offered and Application
4.8 Global Key Manufacturers of Hypericin, Date of Enter into This Industry
4.9 Mergers & Acquisitions, Expansion Plans
5 Market Size by Type
5.1 Global Hypericin Sales by Type
5.1.1 Global Hypericin Historical Sales by Type (2019-2024)
5.1.2 Global Hypericin Forecasted Sales by Type (2025-2030)
5.1.3 Global Hypericin Sales Market Share by Type (2019-2030)
5.2 Global Hypericin Revenue by Type
5.2.1 Global Hypericin Historical Revenue by Type (2019-2024)
5.2.2 Global Hypericin Forecasted Revenue by Type (2025-2030)
5.2.3 Global Hypericin Revenue Market Share by Type (2019-2030)
5.3 Global Hypericin Price by Type
5.3.1 Global Hypericin Price by Type (2019-2024)
5.3.2 Global Hypericin Price Forecast by Type (2025-2030)
6 Market Size by Application
6.1 Global Hypericin Sales by Application
6.1.1 Global Hypericin Historical Sales by Application (2019-2024)
6.1.2 Global Hypericin Forecasted Sales by Application (2025-2030)
6.1.3 Global Hypericin Sales Market Share by Application (2019-2030)
6.2 Global Hypericin Revenue by Application
6.2.1 Global Hypericin Historical Revenue by Application (2019-2024)
6.2.2 Global Hypericin Forecasted Revenue by Application (2025-2030)
6.2.3 Global Hypericin Revenue Market Share by Application (2019-2030)
6.3 Global Hypericin Price by Application
6.3.1 Global Hypericin Price by Application (2019-2024)
6.3.2 Global Hypericin Price Forecast by Application (2025-2030)
7 US & Canada
7.1 US & Canada Hypericin Market Size by Type
7.1.1 US & Canada Hypericin Sales by Type (2019-2030)
7.1.2 US & Canada Hypericin Revenue by Type (2019-2030)
7.2 US & Canada Hypericin Market Size by Application
7.2.1 US & Canada Hypericin Sales by Application (2019-2030)
7.2.2 US & Canada Hypericin Revenue by Application (2019-2030)
7.3 US & Canada Hypericin Sales by Country
7.3.1 US & Canada Hypericin Revenue by Country: 2019 VS 2023 VS 2030
7.3.2 US & Canada Hypericin Sales by Country (2019-2030)
7.3.3 US & Canada Hypericin Revenue by Country (2019-2030)
7.3.4 U.S.
7.3.5 Canada
8 Europe
8.1 Europe Hypericin Market Size by Type
8.1.1 Europe Hypericin Sales by Type (2019-2030)
8.1.2 Europe Hypericin Revenue by Type (2019-2030)
8.2 Europe Hypericin Market Size by Application
8.2.1 Europe Hypericin Sales by Application (2019-2030)
8.2.2 Europe Hypericin Revenue by Application (2019-2030)
8.3 Europe Hypericin Sales by Country
8.3.1 Europe Hypericin Revenue by Country: 2019 VS 2023 VS 2030
8.3.2 Europe Hypericin Sales by Country (2019-2030)
8.3.3 Europe Hypericin Revenue by Country (2019-2030)
8.3.4 Germany
8.3.5 France
8.3.6 U.K.
8.3.7 Italy
8.3.8 Russia
9 China
9.1 China Hypericin Market Size by Type
9.1.1 China Hypericin Sales by Type (2019-2030)
9.1.2 China Hypericin Revenue by Type (2019-2030)
9.2 China Hypericin Market Size by Application
9.2.1 China Hypericin Sales by Application (2019-2030)
9.2.2 China Hypericin Revenue by Application (2019-2030)
10 Asia (excluding China)
10.1 Asia Hypericin Market Size by Type
10.1.1 Asia Hypericin Sales by Type (2019-2030)
10.1.2 Asia Hypericin Revenue by Type (2019-2030)
10.2 Asia Hypericin Market Size by Application
10.2.1 Asia Hypericin Sales by Application (2019-2030)
10.2.2 Asia Hypericin Revenue by Application (2019-2030)
10.3 Asia Hypericin Sales by Region
10.3.1 Asia Hypericin Revenue by Region: 2019 VS 2023 VS 2030
10.3.2 Asia Hypericin Revenue by Region (2019-2030)
10.3.3 Asia Hypericin Sales by Region (2019-2030)
10.3.4 Japan
10.3.5 South Korea
10.3.6 China Taiwan
10.3.7 Southeast Asia
10.3.8 India
11 Middle East, Africa and Latin America
11.1 Middle East, Africa and Latin America Hypericin Market Size by Type
11.1.1 Middle East, Africa and Latin America Hypericin Sales by Type (2019-2030)
11.1.2 Middle East, Africa and Latin America Hypericin Revenue by Type (2019-2030)
11.2 Middle East, Africa and Latin America Hypericin Market Size by Application
11.2.1 Middle East, Africa and Latin America Hypericin Sales by Application (2019-2030)
11.2.2 Middle East, Africa and Latin America Hypericin Revenue by Application (2019-2030)
11.3 Middle East, Africa and Latin America Hypericin Sales by Country
11.3.1 Middle East, Africa and Latin America Hypericin Revenue by Country: 2019 VS 2023 VS 2030
11.3.2 Middle East, Africa and Latin America Hypericin Revenue by Country (2019-2030)
11.3.3 Middle East, Africa and Latin America Hypericin Sales by Country (2019-2030)
11.3.4 Brazil
11.3.5 Mexico
11.3.6 Turkey
11.3.7 Israel
11.3.8 GCC Countries
12 Corporate Profiles
12.1 Aktin Chemicals
12.1.1 Aktin Chemicals Company Information
12.1.2 Aktin Chemicals Overview
12.1.3 Aktin Chemicals Hypericin Capacity, Sales, Price, Revenue and Gross Margin (2019-2024)
12.1.4 Aktin Chemicals Hypericin Product Model Numbers, Pictures, Descriptions and Specifications
12.1.5 Aktin Chemicals Recent Developments
12.2 Youth Healthy
12.2.1 Youth Healthy Company Information
12.2.2 Youth Healthy Overview
12.2.3 Youth Healthy Hypericin Capacity, Sales, Price, Revenue and Gross Margin (2019-2024)
12.2.4 Youth Healthy Hypericin Product Model Numbers, Pictures, Descriptions and Specifications
12.2.5 Youth Healthy Recent Developments
12.3 Hubei Shinrezing Pharmaceutical
12.3.1 Hubei Shinrezing Pharmaceutical Company Information
12.3.2 Hubei Shinrezing Pharmaceutical Overview
12.3.3 Hubei Shinrezing Pharmaceutical Hypericin Capacity, Sales, Price, Revenue and Gross Margin (2019-2024)
12.3.4 Hubei Shinrezing Pharmaceutical Hypericin Product Model Numbers, Pictures, Descriptions and Specifications
12.3.5 Hubei Shinrezing Pharmaceutical Recent Developments
12.4 Herbs-Tech
12.4.1 Herbs-Tech Company Information
12.4.2 Herbs-Tech Overview
12.4.3 Herbs-Tech Hypericin Capacity, Sales, Price, Revenue and Gross Margin (2019-2024)
12.4.4 Herbs-Tech Hypericin Product Model Numbers, Pictures, Descriptions and Specifications
12.4.5 Herbs-Tech Recent Developments
13 Industry Chain and Sales Channels Analysis
13.1 Hypericin Industry Chain Analysis
13.2 Hypericin Key Raw Materials
13.2.1 Key Raw Materials
13.2.2 Raw Materials Key Suppliers
13.3 Hypericin Production Mode & Process
13.4 Hypericin Sales and Marketing
13.4.1 Hypericin Sales Channels
13.4.2 Hypericin Distributors
13.5 Hypericin Customers
14 Hypericin Market Dynamics
14.1 Hypericin Industry Trends
14.2 Hypericin Market Drivers
14.3 Hypericin Market Challenges
14.4 Hypericin Market Restraints
15 Key Finding in The Global Hypericin Study
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
TABLE OF FIGURES
List of Tables
Table 1. Global Hypericin Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
Table 2. Major Manufacturers of 98% Content
Table 3. Major Manufacturers of Other Content
Table 4. Global Hypericin Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
Table 5. Global Hypericin Production by Region: 2019 VS 2023 VS 2030 (Tons)
Table 6. Global Hypericin Production by Region (2019-2024) & (Tons)
Table 7. Global Hypericin Production by Region (2025-2030) & (Tons)
Table 8. Global Hypericin Production Market Share by Region (2019-2024)
Table 9. Global Hypericin Production Market Share by Region (2025-2030)
Table 10. Global Hypericin Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 11. Global Hypericin Revenue by Region (2019-2024) & (US$ Million)
Table 12. Global Hypericin Revenue by Region (2025-2030) & (US$ Million)
Table 13. Global Hypericin Revenue Market Share by Region (2019-2024)
Table 14. Global Hypericin Revenue Market Share by Region (2025-2030)
Table 15. Global Hypericin Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 16. Global Hypericin Sales by Region (2019-2024) & (Tons)
Table 17. Global Hypericin Sales by Region (2025-2030) & (Tons)
Table 18. Global Hypericin Sales Market Share by Region (2019-2024)
Table 19. Global Hypericin Sales Market Share by Region (2025-2030)
Table 20. Global Hypericin Sales by Manufacturers (2019-2024) & (Tons)
Table 21. Global Hypericin Sales Share by Manufacturers (2019-2024)
Table 22. Global Hypericin Revenue by Manufacturers (2019-2024) & (US$ Million)
Table 23. Global Hypericin Revenue Share by Manufacturers (2019-2024)
Table 24. Hypericin Price by Manufacturers 2019-2024 (US$/Ton)
Table 25. Global Key Players of Hypericin, Industry Ranking, 2022 VS 2023 VS 2024
Table 26. Global Hypericin Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 27. Global Hypericin by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hypericin as of 2023)
Table 28. Global Key Manufacturers of Hypericin, Manufacturing Base Distribution and Headquarters
Table 29. Global Key Manufacturers of Hypericin, Product Offered and Application
Table 30. Global Key Manufacturers of Hypericin, Date of Enter into This Industry
Table 31. Mergers & Acquisitions, Expansion Plans
Table 32. Global Hypericin Sales by Type (2019-2024) & (Tons)
Table 33. Global Hypericin Sales by Type (2025-2030) & (Tons)
Table 34. Global Hypericin Sales Share by Type (2019-2024)
Table 35. Global Hypericin Sales Share by Type (2025-2030)
Table 36. Global Hypericin Revenue by Type (2019-2024) & (US$ Million)
Table 37. Global Hypericin Revenue by Type (2025-2030) & (US$ Million)
Table 38. Global Hypericin Revenue Share by Type (2019-2024)
Table 39. Global Hypericin Revenue Share by Type (2025-2030)
Table 40. Hypericin Price by Type (2019-2024) & (US$/Ton)
Table 41. Global Hypericin Price Forecast by Type (2025-2030) & (US$/Ton)
Table 42. Global Hypericin Sales by Application (2019-2024) & (Tons)
Table 43. Global Hypericin Sales by Application (2025-2030) & (Tons)
Table 44. Global Hypericin Sales Share by Application (2019-2024)
Table 45. Global Hypericin Sales Share by Application (2025-2030)
Table 46. Global Hypericin Revenue by Application (2019-2024) & (US$ Million)
Table 47. Global Hypericin Revenue by Application (2025-2030) & (US$ Million)
Table 48. Global Hypericin Revenue Share by Application (2019-2024)
Table 49. Global Hypericin Revenue Share by Application (2025-2030)
Table 50. Hypericin Price by Application (2019-2024) & (US$/Ton)
Table 51. Global Hypericin Price Forecast by Application (2025-2030) & (US$/Ton)
Table 52. US & Canada Hypericin Sales by Type (2019-2024) & (Tons)
Table 53. US & Canada Hypericin Sales by Type (2025-2030) & (Tons)
Table 54. US & Canada Hypericin Revenue by Type (2019-2024) & (US$ Million)
Table 55. US & Canada Hypericin Revenue by Type (2025-2030) & (US$ Million)
Table 56. US & Canada Hypericin Sales by Application (2019-2024) & (Tons)
Table 57. US & Canada Hypericin Sales by Application (2025-2030) & (Tons)
Table 58. US & Canada Hypericin Revenue by Application (2019-2024) & (US$ Million)
Table 59. US & Canada Hypericin Revenue by Application (2025-2030) & (US$ Million)
Table 60. US & Canada Hypericin Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 61. US & Canada Hypericin Revenue by Country (2019-2024) & (US$ Million)
Table 62. US & Canada Hypericin Revenue by Country (2025-2030) & (US$ Million)
Table 63. US & Canada Hypericin Sales by Country (2019-2024) & (Tons)
Table 64. US & Canada Hypericin Sales by Country (2025-2030) & (Tons)
Table 65. Europe Hypericin Sales by Type (2019-2024) & (Tons)
Table 66. Europe Hypericin Sales by Type (2025-2030) & (Tons)
Table 67. Europe Hypericin Revenue by Type (2019-2024) & (US$ Million)
Table 68. Europe Hypericin Revenue by Type (2025-2030) & (US$ Million)
Table 69. Europe Hypericin Sales by Application (2019-2024) & (Tons)
Table 70. Europe Hypericin Sales by Application (2025-2030) & (Tons)
Table 71. Europe Hypericin Revenue by Application (2019-2024) & (US$ Million)
Table 72. Europe Hypericin Revenue by Application (2025-2030) & (US$ Million)
Table 73. Europe Hypericin Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 74. Europe Hypericin Revenue by Country (2019-2024) & (US$ Million)
Table 75. Europe Hypericin Revenue by Country (2025-2030) & (US$ Million)
Table 76. Europe Hypericin Sales by Country (2019-2024) & (Tons)
Table 77. Europe Hypericin Sales by Country (2025-2030) & (Tons)
Table 78. China Hypericin Sales by Type (2019-2024) & (Tons)
Table 79. China Hypericin Sales by Type (2025-2030) & (Tons)
Table 80. China Hypericin Revenue by Type (2019-2024) & (US$ Million)
Table 81. China Hypericin Revenue by Type (2025-2030) & (US$ Million)
Table 82. China Hypericin Sales by Application (2019-2024) & (Tons)
Table 83. China Hypericin Sales by Application (2025-2030) & (Tons)
Table 84. China Hypericin Revenue by Application (2019-2024) & (US$ Million)
Table 85. China Hypericin Revenue by Application (2025-2030) & (US$ Million)
Table 86. Asia Hypericin Sales by Type (2019-2024) & (Tons)
Table 87. Asia Hypericin Sales by Type (2025-2030) & (Tons)
Table 88. Asia Hypericin Revenue by Type (2019-2024) & (US$ Million)
Table 89. Asia Hypericin Revenue by Type (2025-2030) & (US$ Million)
Table 90. Asia Hypericin Sales by Application (2019-2024) & (Tons)
Table 91. Asia Hypericin Sales by Application (2025-2030) & (Tons)
Table 92. Asia Hypericin Revenue by Application (2019-2024) & (US$ Million)
Table 93. Asia Hypericin Revenue by Application (2025-2030) & (US$ Million)
Table 94. Asia Hypericin Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 95. Asia Hypericin Revenue by Region (2019-2024) & (US$ Million)
Table 96. Asia Hypericin Revenue by Region (2025-2030) & (US$ Million)
Table 97. Asia Hypericin Sales by Region (2019-2024) & (Tons)
Table 98. Asia Hypericin Sales by Region (2025-2030) & (Tons)
Table 99. Middle East, Africa and Latin America Hypericin Sales by Type (2019-2024) & (Tons)
Table 100. Middle East, Africa and Latin America Hypericin Sales by Type (2025-2030) & (Tons)
Table 101. Middle East, Africa and Latin America Hypericin Revenue by Type (2019-2024) & (US$ Million)
Table 102. Middle East, Africa and Latin America Hypericin Revenue by Type (2025-2030) & (US$ Million)
Table 103. Middle East, Africa and Latin America Hypericin Sales by Application (2019-2024) & (Tons)
Table 104. Middle East, Africa and Latin America Hypericin Sales by Application (2025-2030) & (Tons)
Table 105. Middle East, Africa and Latin America Hypericin Revenue by Application (2019-2024) & (US$ Million)
Table 106. Middle East, Africa and Latin America Hypericin Revenue by Application (2025-2030) & (US$ Million)
Table 107. Middle East, Africa and Latin America Hypericin Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 108. Middle East, Africa and Latin America Hypericin Revenue by Country (2019-2024) & (US$ Million)
Table 109. Middle East, Africa and Latin America Hypericin Revenue by Country (2025-2030) & (US$ Million)
Table 110. Middle East, Africa and Latin America Hypericin Sales by Country (2019-2024) & (Tons)
Table 111. Middle East, Africa and Latin America Hypericin Sales by Country (2025-2030) & (Tons)
Table 112. Aktin Chemicals Company Information
Table 113. Aktin Chemicals Description and Major Businesses
Table 114. Aktin Chemicals Hypericin Capacity Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 115. Aktin Chemicals Hypericin Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. Aktin Chemicals Recent Development
Table 117. Youth Healthy Company Information
Table 118. Youth Healthy Description and Major Businesses
Table 119. Youth Healthy Hypericin Capacity Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 120. Youth Healthy Hypericin Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. Youth Healthy Recent Development
Table 122. Hubei Shinrezing Pharmaceutical Company Information
Table 123. Hubei Shinrezing Pharmaceutical Description and Major Businesses
Table 124. Hubei Shinrezing Pharmaceutical Hypericin Capacity Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 125. Hubei Shinrezing Pharmaceutical Hypericin Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. Hubei Shinrezing Pharmaceutical Recent Development
Table 127. Herbs-Tech Company Information
Table 128. Herbs-Tech Description and Major Businesses
Table 129. Herbs-Tech Hypericin Capacity Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 130. Herbs-Tech Hypericin Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. Herbs-Tech Recent Development
Table 132. Key Raw Materials Lists
Table 133. Raw Materials Key Suppliers Lists
Table 134. Hypericin Distributors List
Table 135. Hypericin Customers List
Table 136. Hypericin Market Trends
Table 137. Hypericin Market Drivers
Table 138. Hypericin Market Challenges
Table 139. Hypericin Market Restraints
Table 140. Research Programs/Design for This Report
Table 141. Key Data Information from Secondary Sources
Table 142. Key Data Information from Primary Sources
List of Figures
Figure 1. Hypericin Product Picture
Figure 2. Global Hypericin Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Hypericin Market Share by Type in 2023 & 2030
Figure 4. 98% Content Product Picture
Figure 5. Other Content Product Picture
Figure 6. Global Hypericin Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
Figure 7. Global Hypericin Market Share by Application in 2023 & 2030
Figure 8. Nutraceutical
Figure 9. Pharmaceutical
Figure 10. Research
Figure 11. Hypericin Report Years Considered
Figure 12. Global Hypericin Capacity, Production and Utilization (2019-2030) & (Tons)
Figure 13. Global Hypericin Production Market Share by Region in Percentage: 2023 Versus 2030
Figure 14. Global Hypericin Production Market Share by Region (2019-2030)
Figure 15. Hypericin Production Growth Rate in North America (2019-2030) & (Tons)
Figure 16. Hypericin Production Growth Rate in Europe (2019-2030) & (Tons)
Figure 17. Hypericin Production Growth Rate in China (2019-2030) & (Tons)
Figure 18. Hypericin Production Growth Rate in Japan (2019-2030) & (Tons)
Figure 19. Global Hypericin Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 20. Global Hypericin Revenue 2019-2030 (US$ Million)
Figure 21. Global Hypericin Revenue (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Figure 22. Global Hypericin Revenue Market Share by Region in Percentage: 2023 Versus 2030
Figure 23. Global Hypericin Revenue Market Share by Region (2019-2030)
Figure 24. Global Hypericin Sales 2019-2030 ((Tons)
Figure 25. Global Hypericin Sales (CAGR) by Region: 2019 VS 2023 VS 2030 (Tons)
Figure 26. Global Hypericin Sales Market Share by Region (2019-2030)
Figure 27. US & Canada Hypericin Sales YoY (2019-2030) & (Tons)
Figure 28. US & Canada Hypericin Revenue YoY (2019-2030) & (US$ Million)
Figure 29. Europe Hypericin Sales YoY (2019-2030) & (Tons)
Figure 30. Europe Hypericin Revenue YoY (2019-2030) & (US$ Million)
Figure 31. China Hypericin Sales YoY (2019-2030) & (Tons)
Figure 32. China Hypericin Revenue YoY (2019-2030) & (US$ Million)
Figure 33. Asia (excluding China) Hypericin Sales YoY (2019-2030) & (Tons)
Figure 34. Asia (excluding China) Hypericin Revenue YoY (2019-2030) & (US$ Million)
Figure 35. Middle East, Africa and Latin America Hypericin Sales YoY (2019-2030) & (Tons)
Figure 36. Middle East, Africa and Latin America Hypericin Revenue YoY (2019-2030) & (US$ Million)
Figure 37. The Hypericin Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023
Figure 38. The Top 5 and 10 Largest Manufacturers of Hypericin in the World: Market Share by Hypericin Revenue in 2023
Figure 39. Global Hypericin Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 40. Global Hypericin Sales Market Share by Type (2019-2030)
Figure 41. Global Hypericin Revenue Market Share by Type (2019-2030)
Figure 42. Global Hypericin Sales Market Share by Application (2019-2030)
Figure 43. Global Hypericin Revenue Market Share by Application (2019-2030)
Figure 44. US & Canada Hypericin Sales Market Share by Type (2019-2030)
Figure 45. US & Canada Hypericin Revenue Market Share by Type (2019-2030)
Figure 46. US & Canada Hypericin Sales Market Share by Application (2019-2030)
Figure 47. US & Canada Hypericin Revenue Market Share by Application (2019-2030)
Figure 48. US & Canada Hypericin Revenue Share by Country (2019-2030)
Figure 49. US & Canada Hypericin Sales Share by Country (2019-2030)
Figure 50. U.S. Hypericin Revenue (2019-2030) & (US$ Million)
Figure 51. Canada Hypericin Revenue (2019-2030) & (US$ Million)
Figure 52. Europe Hypericin Sales Market Share by Type (2019-2030)
Figure 53. Europe Hypericin Revenue Market Share by Type (2019-2030)
Figure 54. Europe Hypericin Sales Market Share by Application (2019-2030)
Figure 55. Europe Hypericin Revenue Market Share by Application (2019-2030)
Figure 56. Europe Hypericin Revenue Share by Country (2019-2030)
Figure 57. Europe Hypericin Sales Share by Country (2019-2030)
Figure 58. Germany Hypericin Revenue (2019-2030) & (US$ Million)
Figure 59. France Hypericin Revenue (2019-2030) & (US$ Million)
Figure 60. U.K. Hypericin Revenue (2019-2030) & (US$ Million)
Figure 61. Italy Hypericin Revenue (2019-2030) & (US$ Million)
Figure 62. Russia Hypericin Revenue (2019-2030) & (US$ Million)
Figure 63. China Hypericin Sales Market Share by Type (2019-2030)
Figure 64. China Hypericin Revenue Market Share by Type (2019-2030)
Figure 65. China Hypericin Sales Market Share by Application (2019-2030)
Figure 66. China Hypericin Revenue Market Share by Application (2019-2030)
Figure 67. Asia Hypericin Sales Market Share by Type (2019-2030)
Figure 68. Asia Hypericin Revenue Market Share by Type (2019-2030)
Figure 69. Asia Hypericin Sales Market Share by Application (2019-2030)
Figure 70. Asia Hypericin Revenue Market Share by Application (2019-2030)
Figure 71. Asia Hypericin Revenue Share by Region (2019-2030)
Figure 72. Asia Hypericin Sales Share by Region (2019-2030)
Figure 73. Japan Hypericin Revenue (2019-2030) & (US$ Million)
Figure 74. South Korea Hypericin Revenue (2019-2030) & (US$ Million)
Figure 75. China Taiwan Hypericin Revenue (2019-2030) & (US$ Million)
Figure 76. Southeast Asia Hypericin Revenue (2019-2030) & (US$ Million)
Figure 77. India Hypericin Revenue (2019-2030) & (US$ Million)
Figure 78. Middle East, Africa and Latin America Hypericin Sales Market Share by Type (2019-2030)
Figure 79. Middle East, Africa and Latin America Hypericin Revenue Market Share by Type (2019-2030)
Figure 80. Middle East, Africa and Latin America Hypericin Sales Market Share by Application (2019-2030)
Figure 81. Middle East, Africa and Latin America Hypericin Revenue Market Share by Application (2019-2030)
Figure 82. Middle East, Africa and Latin America Hypericin Revenue Share by Country (2019-2030)
Figure 83. Middle East, Africa and Latin America Hypericin Sales Share by Country (2019-2030)
Figure 84. Brazil Hypericin Revenue (2019-2030) & (US$ Million)
Figure 85. Mexico Hypericin Revenue (2019-2030) & (US$ Million)
Figure 86. Turkey Hypericin Revenue (2019-2030) & (US$ Million)
Figure 87. Israel Hypericin Revenue (2019-2030) & (US$ Million)
Figure 88. GCC Countries Hypericin Revenue (2019-2030) & (US$ Million)
Figure 89. Hypericin Value Chain
Figure 90. Hypericin Production Process
Figure 91. Channels of Distribution
Figure 92. Distributors Profiles
Figure 93. Bottom-up and Top-down Approaches for This Report
Figure 94. Data Triangulation
Figure 95. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
What was the global market size of Hypericin in 2024?
The global market size of Hypericin in 2024 was 46 Million USD.
What is the annual compound growth rate of the global Hypericin market size from 2024 to 2030?
Which companies rank high in the global Hypericin market?
Which region is expected to have the highest market share?
What was the global market size of Hypericin in 2030?
Related Reports
Hypericin- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Hypericin was estimated to be worth US$ 51.71 million in 2025 and is projected to reach US$ 80.92 million, growing at a CAGR of 6.7% from 2026 to 2032.
Published Date: 2026-06-16
Pages: 124
USD 3950.00
(Single User License)
Global Hypericin Market Research Report 2026
The global Hypericin market was valued at US$ 51.71 million in 2025 and is anticipated to reach US$ 80.92 million by 2032, at a CAGR of 6.7% from 2026 to 2032.
Published Date: 2026-04-18
Pages: 120
USD 2900.00
(Single User License)
Global Hypericin Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Hypericin market size was US$ 48.8 million in 2024 and is forecast to a readjusted size of US$ 76.3 million by 2031 with a CAGR of 6.7% during the forecast period 2025-2031.
Published Date: 2025-11-02
Pages: 73
USD 4250.00
(Single User License)
Global Hypericin Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Hypericin market is projected to grow from US$ 48.8 million in 2024 to US$ 76.3 million by 2031, at a CAGR of 6.7% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-11-02
Pages: 129
USD 4900.00
(Single User License)
Global Hypericin Market Research Report 2025
The global market for Hypericin was valued at US$ 48.8 million in the year 2024 and is projected to reach a revised size of US$ 76.3 million by 2031, growing at a CAGR of 6.7% during the forecast period.
Published Date: 2025-01-16
Pages: 84
USD 2900.00
(Single User License)
Hypericin- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Hypericin was estimated to be worth US$ 48.8 million in 2024 and is forecast to a readjusted size of US$ 76.3 million by 2031 with a CAGR of 6.7% during the forecast period 2025-2031.
Published Date: 2025-01-13
Pages: 84
USD 3950.00
(Single User License)
Global Hypericin Market Research Report 2024
Hypericin is a natural compound found in the flowering plant Hypericum perforatum, commonly known as St. John's Wort. It is a red pigment with photodynamic and antiviral properties. Hypericin has been extensively studied for its potential therapeutic applications, including as an antidepressant, antiviral agent, and anticancer compound. It is known to interact with various biological mechanisms and has shown promising results in laboratory studies for its ability to inhibit viral replication and induce apoptosis in cancer cells. Hypericin's unique chemical structure makes it an intriguing compound for further exploration in pharmaceutical research and medical treatments.
Published Date: 2024-01-17
Pages: 79
USD 2900.00
(Single User License)
Hypericin - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Hypericin is a natural compound found in the flowering plant Hypericum perforatum, commonly known as St. John's Wort. It is a red pigment with photodynamic and antiviral properties. Hypericin has been extensively studied for its potential therapeutic applications, including as an antidepressant, antiviral agent, and anticancer compound. It is known to interact with various biological mechanisms and has shown promising results in laboratory studies for its ability to inhibit viral replication and induce apoptosis in cancer cells. Hypericin's unique chemical structure makes it an intriguing compound for further exploration in pharmaceutical research and medical treatments.
Published Date: 2024-01-10
Pages: 84
USD 3950.00
(Single User License)
Hypericin- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Hypericin was estimated to be worth US$ 51.71 million in 2025 and is projected to reach US$ 80.92 million, growing at a CAGR of 6.7% from 2026 to 2032.
Published: 2026-06-16
Pages: 124
USD 3950.00 (Single User License)Global Hypericin Market Research Report 2026
The global Hypericin market was valued at US$ 51.71 million in 2025 and is anticipated to reach US$ 80.92 million by 2032, at a CAGR of 6.7% from 2026 to 2032.
Published: 2026-04-18
Pages: 120
USD 2900.00 (Single User License)Global Hypericin Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Hypericin market size was US$ 48.8 million in 2024 and is forecast to a readjusted size of US$ 76.3 million by 2031 with a CAGR of 6.7% during the forecast period 2025-2031.
Published: 2025-11-02
Pages: 73
USD 4250.00 (Single User License)Global Hypericin Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Hypericin market is projected to grow from US$ 48.8 million in 2024 to US$ 76.3 million by 2031, at a CAGR of 6.7% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-11-02
Pages: 129
USD 4900.00 (Single User License)Global Hypericin Market Research Report 2025
The global market for Hypericin was valued at US$ 48.8 million in the year 2024 and is projected to reach a revised size of US$ 76.3 million by 2031, growing at a CAGR of 6.7% during the forecast period.
Published: 2025-01-16
Pages: 84
USD 2900.00 (Single User License)Hypericin- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Hypericin was estimated to be worth US$ 48.8 million in 2024 and is forecast to a readjusted size of US$ 76.3 million by 2031 with a CAGR of 6.7% during the forecast period 2025-2031.
Published: 2025-01-13
Pages: 84
USD 3950.00 (Single User License)Global Hypericin Market Research Report 2024
Hypericin is a natural compound found in the flowering plant Hypericum perforatum, commonly known as St. John's Wort. It is a red pigment with photodynamic and antiviral properties. Hypericin has been extensively studied for its potential therapeutic applications, including as an antidepressant, antiviral agent, and anticancer compound. It is known to interact with various biological mechanisms and has shown promising results in laboratory studies for its ability to inhibit viral replication and induce apoptosis in cancer cells. Hypericin's unique chemical structure makes it an intriguing compound for further exploration in pharmaceutical research and medical treatments.
Published: 2024-01-17
Pages: 79
USD 2900.00 (Single User License)Hypericin - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Hypericin is a natural compound found in the flowering plant Hypericum perforatum, commonly known as St. John's Wort. It is a red pigment with photodynamic and antiviral properties. Hypericin has been extensively studied for its potential therapeutic applications, including as an antidepressant, antiviral agent, and anticancer compound. It is known to interact with various biological mechanisms and has shown promising results in laboratory studies for its ability to inhibit viral replication and induce apoptosis in cancer cells. Hypericin's unique chemical structure makes it an intriguing compound for further exploration in pharmaceutical research and medical treatments.
Published: 2024-01-10
Pages: 84
USD 3950.00 (Single User License)
CHOOSE LICENSE TYPE
USD 4900.00
USD 7350.00
USD 9800.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now